A Phase II Study of Fruquintinib in the First- (1L) or Second-Line (2L) Treatment of Unresectable Metastatic Soft Tissue SarcomaZhiguo Luo,Xiaowei Zhang, Ting Zhao,Bi-Qiang Zheng,Wangjun Yan,Yong Chen,Yu Xu,Chun-Meng Wang, Junhua Zhang,Jian Wang,Lin Yu,Xin LiuJOURNAL OF CLINICAL ONCOLOGY（2023）引用 0|浏览27暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
